lactic acid has been researched along with Bone Diseases, Metabolic in 6 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Suspected antiretroviral toxicities meeting these criteria include: HIV-associated lipodystrophy which can include peripheral lipoatrophy, lipohypertrophy and metabolic abnormalities; hyperlactatemia and lactic acidosis; and metabolic bone abnormalities such as decreased bone mineral density, osteoporosis and osteonecrosis." | 4.82 | Emerging drug toxicities of highly active antiretroviral therapy for human immunodeficiency virus (HIV) infection. ( Bondy, G; Heath, KV; Hogg, RS; Montaner, JS; O'Shaughnessy, MV; Singer, J, 2003) |
| "Osteopenia has been associated with antiretroviral therapy, particularly with protease inhibitors." | 1.31 | Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. ( Carr, A; Cooper, DA; Eisman, JA; Miller, J, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gunnella, F | 1 |
| Kunisch, E | 1 |
| Maenz, S | 1 |
| Horbert, V | 1 |
| Xin, L | 1 |
| Mika, J | 1 |
| Borowski, J | 1 |
| Bischoff, S | 1 |
| Schubert, H | 1 |
| Sachse, A | 1 |
| Illerhaus, B | 1 |
| Günster, J | 1 |
| Bossert, J | 1 |
| Jandt, KD | 1 |
| Plöger, F | 1 |
| Kinne, RW | 1 |
| Brinkmann, O | 1 |
| Bungartz, M | 1 |
| Roca, B | 1 |
| Schambelan, M | 1 |
| Benson, CA | 1 |
| Carr, A | 2 |
| Currier, JS | 1 |
| Dubé, MP | 1 |
| Gerber, JG | 1 |
| Grinspoon, SK | 1 |
| Grunfeld, C | 1 |
| Kotler, DP | 1 |
| Mulligan, K | 1 |
| Powderly, WG | 1 |
| Saag, MS | 1 |
| Heath, KV | 1 |
| Montaner, JS | 1 |
| Bondy, G | 1 |
| Singer, J | 1 |
| O'Shaughnessy, MV | 1 |
| Hogg, RS | 1 |
| Haugaard, SB | 1 |
| Miller, J | 1 |
| Eisman, JA | 1 |
| Cooper, DA | 1 |
4 reviews available for lactic acid and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Adverse drug reactions to antiretroviral medication.
Topics: Anti-HIV Agents; Bone Diseases, Metabolic; Bone Marrow; Cardiovascular System; Drug Hypersensitivity | 2009 |
Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.
Topics: Adipose Tissue; Anti-HIV Agents; Bone Diseases, Metabolic; Glucose; HIV Infections; HIV-1; Homeostas | 2002 |
Emerging drug toxicities of highly active antiretroviral therapy for human immunodeficiency virus (HIV) infection.
Topics: Acidosis, Lactic; Antiretroviral Therapy, Highly Active; Bone Diseases, Metabolic; DNA, Mitochondria | 2003 |
Toxic metabolic syndrome associated with HAART.
Topics: Adiponectin; Adipose Tissue; Animals; Antiretroviral Therapy, Highly Active; Bone Diseases, Metaboli | 2006 |
2 other studies available for lactic acid and Bone Diseases, Metabolic
| Article | Year |
|---|---|
The GDF5 mutant BB-1 enhances the bone formation induced by an injectable, poly(l-lactide-co-glycolide) acid (PLGA) fiber-reinforced, brushite-forming cement in a sheep defect model of lumbar osteopenia.
Topics: Animals; Bone Cements; Bone Density; Bone Diseases, Metabolic; Bone Regeneration; Compressive Streng | 2018 |
Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.
Topics: Absorptiometry, Photon; Acidosis, Lactic; Adult; Anti-HIV Agents; Body Composition; Body Weight; Bon | 2001 |